Norway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact
Norway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact
Overview
Norway diagnostics firm's Q1 sales revenue rose 60% yr/yr, driven by GA-map kit demand
Gross margin declined to 73.2% due to US customs duties and weaker USD
Company secured new patents in Canada and US, launched AI-assisted interpretation platform
Outlook
Company did not provide specific guidance or financial outlook for the current qtr or yr in press release
Result Drivers
REAGENT KIT SALES - Growth in recurring GA-map reagent kit sales drove Q1 revenue increase
CURRENCY AND DUTIES - Gross margin declined due to US customs duties and weaker USD
Company press release: ID:nWkrbdw1Ss
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q1 Sales |
| NOK 3.8 mln |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Genetic Analysis As
See all newsNorway's Genetic Analysis Q1 gross margin hurt by US duties, currency impact
Brief: Genetic Analysis As 9 Month Operating Income Amounted To Nok 16,8 Million (Nok 15,1 Million)
Brief: Genetic Analysis Q3 Net Income NOK -4.3 Million
Brief: Genetic Analysis Q2 Sales at NOK 3.7 Million
Brief: Genetic Analysis Ramps Up Market Presence For Ga-Map Microbiome Testing In U.S.